Abstract:BackgroundSubpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is a multi-center longitudinal, observational study to identify novel phenotypes and biomarkers of chronic obstructive pulmonary disease (COPD). In a subset of 300 subjects enrolled at six clinical centers, we are performing flow cytometric analyses of leukocytes from induced sputum, bronchoalveolar lavage (BAL) and peripheral blood. To minimize several sources of variability, we use a “just-in-time” design that permits immediate staining without pre-fixation of samples, followed by centralized analysis on a single instrument.MethodsThe Immunophenotyping Core prepares 12-color antibody panels, which are shipped to the six Clinical Centers shortly before study visits. Sputum induction occurs at least two weeks before a bronchoscopy visit, at which time peripheral blood and bronchoalveolar lavage are collected. Immunostaining is performed at each clinical site on the day that the samples are collected. Samples are fixed and express shipped to the Immunophenotyping Core for data acquisition on a single modified LSR II flow cytometer. Results are analyzed using FACS Diva and FloJo software and cross-checked by Core scientists who are blinded to subject data.ResultsThus far, a total of 152 sputum samples and 117 samples of blood and BAL have been returned to the Immunophenotyping Core. Initial quality checks indicate useable data from 126 sputum samples (83%), 106 blood samples (91%) and 91 BAL samples (78%). In all three sample types, we are able to identify and characterize the activation state or subset of multiple leukocyte cell populations (including CD4+ and CD8+ T cells, B cells, monocytes, macrophages, neutrophils and eosinophils), thereby demonstrating the validity of the antibody panel.ConclusionsOur study design, which relies on bi-directional communication between clinical centers and the Core according to a pre-specified protocol, appears to reduce several sources of variability often seen in flow cytometric studies involving multiple clinical sites. Because leukocytes contribute to lung pathology in COPD, these analyses will help achieve SPIROMICS aims of identifying subgroups of patients with specific COPD phenotypes. Future analyses will correlate cell-surface markers on a given cell type with smoking history, spirometry, airway measurements, and other parameters.Trial registrationThis study was registered with ClinicalTrials.gov as NCT01969344.

Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study

Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

Design of the SPIROMICS Study of Early COPD Progression: SOURCE Study

Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary Disease

Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease

A Prospective Study of Salvational Intervention with ICS/LABA for Reducing Chronic Obstructive Pulmonary Disease Exacerbation under Severe Air Pollution (SIRCAP) in Beijing: Protocol of a Multi-Center Randomized Controlled Trial

Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study

Protocol for the air purification for eosinophilic COPD study (APECS): a randomised controlled trial of home air filtration by HEPA

Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study)

Systemic Alterations in Neutrophils and Their Precursors in Early-Stage Chronic Obstructive Pulmonary Disease

Susceptibility of Individuals with Lung Dysfunction to Systemic Inflammation Associated with Ambient Fine Particle Exposure: A Panel Study in Beijing.

Susceptibility of Individuals with Chronic Obstructive Pulmonary Disease to Air Pollution Exposure in Beijing, China: A Case-Control Panel Study (COPDB).

Rationale and design of the Early Chronic Obstructive Pulmonary Disease (ECOPD) study in Guangdong, China: a prospective observational cohort study

Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study

Long-term exposure to outdoor air pollution and asthma in low-and middle-income countries: A systematic review protocol

Susceptibility of Individuals with Chronic Obstructive Pulmonary Disease to Respiratory Inflammation Associated with Short-Term Exposure to Ambient Air Pollution: A Panel Study in Beijing

Study on risk factors and phenotypes of acute exacerbations of chronic obstructive pulmonary disease in Guangzhou, China-design and baseline characteristics

The Effect of Chronic Altitude Exposure on COPD Outcomes in the SPIROMICS Cohort

Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort

Susceptibility of individuals with COPD to the health effects of air pollution: a nested case-control panel study in Beijing, China

Association of multiple air pollutants with oxygen saturation during sleep in COPD patients: Effect modification by smoking status and airway inflammatory phenotypes